Gene Therapy Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gene Therapy stocks.

Gene Therapy Stocks Recent News

Date Stock Title
May 13 VYGR Voyager Therapeutics up 8% following quarterly beats
May 13 VYGR Voyager Therapeutics (VYGR) Reports Q1 Loss, Tops Revenue Estimates
May 13 VYGR Voyager Therapeutics GAAP EPS of -$0.20 beats by $0.24, revenue of $19.5M beats by $10.02M
May 13 VYGR Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
May 13 MRVI TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
May 13 MGTX Analyst Forecasts For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
May 12 TNYA 13 Penny Stocks with Insider Buying in 2024
May 11 RGNX Analysts Have Lowered Expectations For REGENXBIO Inc. (NASDAQ:RGNX) After Its Latest Results
May 10 MGTX MeiraGTx Holdings PLC Reports First Quarter 2024 Financial Results
May 10 RGNX Regenxbio Inc (RGNX) Q1 2024 Earnings: Misses Analyst Revenue and EPS Forecasts
May 10 MRVI Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 10 MGTX MeiraGTx Holdings First Quarter 2024 Earnings: US$0.32 loss per share (vs US$0.62 loss in 1Q 2023)
May 9 MRVI Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript
May 9 MRVI Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
May 9 RGNX REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
May 9 MGTX MeiraGTx GAAP EPS of -$0.32, revenue of $0.69M
May 9 MGTX MeiraGTx Reports First Quarter 2024 Financial and Operational Results
May 9 CRGX Is There An Opportunity With CARGO Therapeutics, Inc.'s (NASDAQ:CRGX) 21% Undervaluation?
May 9 RGNX Q1 2024 Regenxbio Inc Earnings Call
May 9 MRVI Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
Gene Therapy

In the medicine field, gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. The first attempt at modifying human DNA was performed in 1980 by Martin Cline, but the first successful nuclear gene transfer in humans, approved by the National Institutes of Health, was performed in May 1989. The first therapeutic use of gene transfer as well as the first direct insertion of human DNA into the nuclear genome was performed by French Anderson in a trial starting in September 1990.
Between 1989 and February 2016, over 2,300 clinical trials were conducted, with more than half of them in phase I.
Not all medical procedures that introduce alterations to a patient's genetic makeup can be considered gene therapy. Bone marrow transplantation and organ transplants in general have been found to introduce foreign DNA into patients. Gene therapy is defined by the precision of the procedure and the intention of direct therapeutic effect.

Browse All Tags